A carregar...
The serum metabolomics signature of type 2 diabetes is obscured in Alzheimer’s disease
There is evidence for systemic metabolic impairment in Alzheimer’s disease (AD), and type 2 diabetes (T2D) increases AD risk. Although studies analyzing blood metabolomics signatures have shown differences between cognitively healthy (CH) and AD subjects, these signatures have not been compared with...
Na minha lista:
| Publicado no: | Am J Physiol Endocrinol Metab |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Physiological Society
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6032067/ https://ncbi.nlm.nih.gov/pubmed/29351484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00377.2017 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|